For decades, we’ve prioritized heart health, cancer, and longevity but we’ve overlooked the most important organ: the brain. That’s changing now.
Ahead of Alzheimer’s is at the forefront of a new era, one where brain health and wellness become a national priority, early detection becomes standard, and Alzheimer’s is no longer a passive diagnosis, but an active, manageable condition.
This podcast brings together patients, families, caregivers, clinicians, researchers, policymakers, and thought leaders to explore the science, stories, breakthroughs, and policy conversations that can help people understand risk, recognize possibility, and act sooner.
Through conversations grounded in hope, inspiration, information, and action, Ahead of Alzheimer’s helps move the national dialogue forward.
Whether you are living close to the disease or working to change the systems around it, this podcast is a place to hear from the people helping America think differently about Alzheimer’s.
It’s time to have a meaningful conversation on brain wellness.
Alzheimer’s affects millions of Americans and can begin years before symptoms appear. That means the conversation cannot start at diagnosis.
For decades, the healthcare system has only responded after clear signs of cognitive loss appear, defaulting to late-stage crisis management.
Ahead of Alzheimer’s was created to challenge that passive approach.
We are tracking a major cultural shift — one where science, innovation, policy, and care work together to transform how our nation protects its cognitive health.
That shift matters because the earlier we act, the more opportunity we have to to make lifestyle changes and preserve what matters medically, emotionally, and financially.
This is not the end of the story.
We can do something about it.
Today, 7.4 million Americans are living with Alzheimer’s. That number is expected to nearly double by 2060, and the cost of care is projected to reach $409 billion in 2026 alone.
Behind these numbers are nearly 13 million Americans providing unpaid care for a family member or friend, shouldering immense emotional and financial strain.
However, new research into risk factors, biomarkers, lifestyle, genetics, inflammation, metabolism, and brain health is changing what we know about when the disease starts — and when action may matter most.
Because biological changes in the brain can begin decades before outward symptoms appear, greater awareness, transparency, and open dialogue are absolutely critical.
Early action changes outcomes and gives people more time to adopt brain-healthy lifestyle habits. By identifying early markers of decline, families can access vital clinical and emotional support, make proactive lifestyle adjustments, and manage disease progression more effectively.
Today, 7.4 million Americans are living with Alzheimer’s. That number is expected to nearly double by 2060, and the cost of care is projected to reach $409 billion in 2026 alone.
Behind these numbers are nearly 13 million Americans providing unpaid care for a family member or friend, shouldering immense emotional and financial strain.
However, new research into risk factors, biomarkers, lifestyle, genetics, inflammation, metabolism, and brain health is changing what we know about when the disease starts — and when action may matter most.
Because biological changes in the brain can begin decades before outward symptoms appear, greater awareness, transparency, and open dialogue are absolutely critical.
Early action changes outcomes and gives people more time to adopt brain-healthy lifestyle habits. By identifying early markers of decline, families can access vital clinical and emotional, make proactive lifestyle adjustments, and manage disease progression more effectively.
Ahead of Alzheimer’s is in association with Rebuild Medicine, a non-partisan, evidence-based coalition of clinicians and health leaders working to put patients back at the center of healthcare.
By prioritizing scientific rigor and open dialogue, Rebuild Medicine is elevating brain wellness and making Alzheimer’s disease a national public health priority.
Through their support, Ahead of Alzheimer’s can help bring more voices into the conversation and connect science, policy, care, and public awareness in one place.
Emily Kaplan is CEO and Co-founder of The Broken Science Initiative, as well as a strategist, communicator, journalist, entrepreneur, and host leading candid conversations on health and wellness, prevention, treatment, policy, and care.
Ahead of Alzheimer’s is a brain health and wellness show focused on Alzheimer’s prevention, early detection, treatment, care, policy, and stories of hope. The show brings together patients, caregivers, experts, and leaders to explore how America can think differently and act earlier.
Ahead of Alzheimer’s focuses on hope, action, and possibility. The show looks beyond diagnosis to explore prevention, early detection, treatment, care, policy, breakthroughs, and the stories that can change how we think about the disease.
Policy affects research funding, early detection, access to treatment, caregiver support, care delivery, and public health education. As science advances, policy must keep pace so more people can benefit from Alzheimer’s breakthroughs and innovative care models.
Ahead of Alzheimer’s is your go-to resource from initial screening to everyday support.
Whether you are facing Alzheimer’s, supporting someone you love, or working to change the future of care, this is a place to have honest conversations, explore expert perspectives, and hear stories that inform and inspire.
Have a question, guest recommendation, story idea, partnership opportunity, or media inquiry? We’d like to hear from you.